GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » Investments And Advances

ANGLE (ANPCF) Investments And Advances : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ANGLE Investments And Advances?

ANGLE's Investments And Advances for the quarter that ended in Jun. 2023 was $0.00 Mil.


ANGLE Investments And Advances Historical Data

The historical data trend for ANGLE's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Investments And Advances Chart

ANGLE Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ANGLE Semi-Annual Data
Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ANGLE Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


ANGLE (ANPCF) Business Description

Traded in Other Exchanges
Address
10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCF) Headlines

From GuruFocus

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire 04-12-2019

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE 04-30-2021